Cancer Treatment Research Foundation   Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2002
NCT00228319
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now